Lista de obras - Mohamed El Kassas - Dominio Público Uruguay

A Comparison of Presentation, Treatment, and Survival After Hepatocellular Carcinoma of Viral and Non-Viral Etiology in Damietta, Egypt, 2007–2019

artículo científico publicado en 2024

A new potent NS5A inhibitor in the management of hepatitis C virus: ravidasvir.

artículo científico publicado en 2017

After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal.

artículo científico publicado en 2017

Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide

scientific article published on 29 January 2019

An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.

artículo científico publicado en 2018

Chitinase 3- like 1, Tolloid-like Protein 1 and Intergenic Gene Polymorphisms are Predictors for Hepatocellular Carcinoma Development after HCV Eradication by Direct-Acting Antivirals

artículo científico publicado en 2020

Clinical impact of serum α-fetoprotein and its relation on changes in liver fibrosis in hepatitis C virus patients receiving direct-acting antivirals

scientific article published on 01 September 2019

Correction to: Prevalence of prolonged QT interval in patients with HCV-related chronic liver disease

scientific article published on 29 October 2019

Diabetes Association with Liver Diseases: An Overview for Clinicians

artículo científico publicado en 2019

Discovery and preclinical development of dasabuvir for the treatment of hepatitis C infection.

artículo científico publicado en 2017

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease

artículo científico publicado en 2018

Egyptian liver library: An indexed database for liver disease evidence in Egypt

artículo científico publicado en 2019

Egyptian liver library: Rebuilding the pyramid of liver disease evidence in Egypt.

artículo científico publicado en 2017

Elbasvir and grazoprevir for chronic hepatitis C genotypes 1 and 4.

artículo científico publicado en 2016

Emergency endoscopic variceal band ligation in a COVID-19 patient presented with hematemesis while on mechanical ventilation

scientific article published on 14 April 2020

Endoscopic Ultrasound-Guided Fine Needle Aspiration versus Percutaneous Ultrasound-Guided Fine Needle Aspiration in Diagnosis of Focal Pancreatic Masses

artículo científico publicado en 2013

Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis

artículo científico publicado en 2018

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt.

artículo científico publicado en 2017

HCV in Egypt, prevention, treatment and key barriers to elimination

artículo científico publicado en 2018

Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

artículo científico publicado en 2017

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves

scientific article published on 19 November 2019

Herpes Zoster reactivation in patients with chronic hepatitis C under treatment with directly acting antiviral agents: A case series.

artículo científico publicado en 2017

High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

scientific article published on 23 June 2019

How to optimize HCV therapy in genotype 4 patients.

artículo científico

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review

artículo científico publicado en 2019

Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.

artículo científico publicado en 2014

Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.

artículo científico publicado en 2009

Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis.

artículo científico publicado en 2017

Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt.

artículo científico publicado en 2014

Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt

scientific article published on 01 June 2018

Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients

artículo científico publicado en 2019

Managing diabetes and liver disease association

scientific article published on 09 November 2018

Managing diabetes and liver disease association: Practice guidelines from the Egyptian Association for the Study of Liver and Gastrointestinal Disease (EASLGD)

artículo científico publicado en 2019

MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.

artículo científico publicado en 2018

Microwave ablation in the spleen versus partial splenic artery embolisation: A new technique for hypersplenism in cirrhosis.

artículo científico publicado en 2017

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care

artículo científico publicado en 2017

New era for management of chronic hepatitis C virus using direct antiviral agents: A review

artículo científico publicado en 2015

Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs. PEG-IFN alfa 2b; the debate continues.

artículo científico

Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians.

artículo científico publicado en 2010

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients

artículo científico publicado en 2016

Real-Life Efficacy of 5 Different Antiviral Regimens for Treatment of Chronic Hepatitis C With Normal Liver Enzymes

scientific article published on 01 November 2018

Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data.

artículo científico publicado en 2018

Safety of direct antiviral agents in the management of hepatitis C.

artículo científico publicado en 2016

Safety-Engineered Syringes: An Intervention to Decrease Hepatitis C Burden in Developing Countries-A Cost-Effectiveness Analysis From Egypt

artículo científico publicado en 2019

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients with Chronic Hepatitis C: Real-world Results from 1716 Patients in Egypt

scientific article published on 01 January 2019

Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience

artículo científico publicado en 2018

The future for the treatment of genotype 4 chronic hepatitis C.

artículo científico

Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations

artículo científico publicado en 2018

Lista de obras de Mohamed El Kassas

A Comparison of Presentation, Treatment, and Survival After Hepatocellular Carcinoma of Viral and Non-Viral Etiology in Damietta, Egypt, 2007–2019

A new potent NS5A inhibitor in the management of hepatitis C virus: ravidasvir.

After successful hepatitis C virus antiviral therapy: It looks that normal alanine aminotransferase level is not the normal.

Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide

An account of the real-life hepatitis C management in a single specialized viral hepatitis treatment centre in Egypt: results of treating 7042 patients with 7 different direct acting antiviral regimens.

Chitinase 3- like 1, Tolloid-like Protein 1 and Intergenic Gene Polymorphisms are Predictors for Hepatocellular Carcinoma Development after HCV Eradication by Direct-Acting Antivirals

Clinical impact of serum α-fetoprotein and its relation on changes in liver fibrosis in hepatitis C virus patients receiving direct-acting antivirals

Correction to: Prevalence of prolonged QT interval in patients with HCV-related chronic liver disease

Diabetes Association with Liver Diseases: An Overview for Clinicians

Discovery and preclinical development of dasabuvir for the treatment of hepatitis C infection.

Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease

Egyptian liver library: An indexed database for liver disease evidence in Egypt

Egyptian liver library: Rebuilding the pyramid of liver disease evidence in Egypt.

Elbasvir and grazoprevir for chronic hepatitis C genotypes 1 and 4.

Emergency endoscopic variceal band ligation in a COVID-19 patient presented with hematemesis while on mechanical ventilation

Endoscopic Ultrasound-Guided Fine Needle Aspiration versus Percutaneous Ultrasound-Guided Fine Needle Aspiration in Diagnosis of Focal Pancreatic Masses

Five Fibrosis Biomarkers Together with Serum Ferritin Level to Diagnose Liver Fibrosis and Cirrhosis

Generic daclatasvir plus sofosbuvir, with or without ribavirin, in treatment of chronic hepatitis C: real-world results from 18 378 patients in Egypt.

HCV in Egypt, prevention, treatment and key barriers to elimination

Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves

Herpes Zoster reactivation in patients with chronic hepatitis C under treatment with directly acting antiviral agents: A case series.

High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

How to optimize HCV therapy in genotype 4 patients.

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review

Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.

Improvement of steatosis after interferon therapy in HCV genotype 4 is related to weight loss.

Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis.

Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt.

Letter: concordance of SVR4 and SVR12 following direct-acting anti-viral treatment in Egypt

Liver stiffness measurements and FIB-4 are predictors of response to sofosbuvir-based treatment regimens in 7256 chronic HCV patients

Managing diabetes and liver disease association

Managing diabetes and liver disease association: Practice guidelines from the Egyptian Association for the Study of Liver and Gastrointestinal Disease (EASLGD)

MicroRNA Signatures for circulating CD133-positive cells in hepatocellular carcinoma with HCV infection.

Microwave ablation in the spleen versus partial splenic artery embolisation: A new technique for hypersplenism in cirrhosis.

National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care

New era for management of chronic hepatitis C virus using direct antiviral agents: A review

Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs. PEG-IFN alfa 2b; the debate continues.

Prevalence of rheumatologic manifestations of chronic hepatitis C virus infection among Egyptians.

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients

Real-Life Efficacy of 5 Different Antiviral Regimens for Treatment of Chronic Hepatitis C With Normal Liver Enzymes

Risk of hepatitis B virus reactivation with direct-acting antivirals against hepatitis C virus: A cohort study from Egypt and meta-analysis of published data.

Safety of direct antiviral agents in the management of hepatitis C.

Safety-Engineered Syringes: An Intervention to Decrease Hepatitis C Burden in Developing Countries-A Cost-Effectiveness Analysis From Egypt

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients with Chronic Hepatitis C: Real-world Results from 1716 Patients in Egypt

Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience

The future for the treatment of genotype 4 chronic hepatitis C.

Towards hepatitis C virus elimination: Egyptian experience, achievements and limitations